Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy

JL Carter, K Hege, J Yang, HA Kalpage, Y Su… - Signal transduction and …, 2020 - nature.com
Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and the
second most common form of acute leukemia in children. Despite this, very little …

HDAC inhibitors in acute myeloid leukemia

E San José-Enériz, N Gimenez-Camino, X Agirre… - Cancers, 2019 - mdpi.com
Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled
proliferation, differentiation arrest, and accumulation of immature myeloid progenitors …

Molecular and therapeutic potential and toxicity of valproic acid

S Chateauvieux, F Morceau, M Dicato… - BioMed Research …, 2010 - Wiley Online Library
Valproic acid (VPA), a branched short‐chain fatty acid, is widely used as an antiepileptic
drug and a mood stabilizer. Antiepileptic properties have been attributed to inhibition of …

Sensitization of drug resistant cancer cells: a matter of combination therapy

M Leary, S Heerboth, K Lapinska, S Sarkar - Cancers, 2018 - mdpi.com
Cancer drug resistance is an enormous problem. It is responsible for most relapses in
cancer patients following apparent remission after successful therapy. Understanding …

Retinoids, retinoic acid receptors, and cancer

XH Tang, LJ Gudas - Annual Review of Pathology: Mechanisms …, 2011 - annualreviews.org
Retinoids (ie, vitamin A, all-trans retinoic acid, and related signaling molecules) induce the
differentiation of various types of stem cells. Nuclear retinoic acid receptors mediate most but …

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

O Khan, NB La Thangue - Immunology and cell biology, 2012 - Wiley Online Library
Reversible acetylation mediated by histone deacetylases (HDACs) influences a broad
repertoire of physiological processes, many of which are aberrantly controlled in tumor cells …

[HTML][HTML] HDAC inhibitor-based therapies: can we interpret the code?

M New, H Olzscha, NB La Thangue - Molecular oncology, 2012 - Elsevier
Abnormal epigenetic control is a common early event in tumour progression, and aberrant
acetylation in particular has been implicated in tumourigenesis. One of the most promising …

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

N Khan, M Jeffers, S Kumar, C Hackett… - Biochemical …, 2008 - portlandpress.com
The human HDAC (histone deacetylase) family, a well-validated anticancer target, plays a
key role in the control of gene expression through regulation of transcription. While HDACs …

A mutation in the thyroid hormone receptor alpha gene

E Bochukova, N Schoenmakers… - … England Journal of …, 2012 - Mass Medical Soc
Thyroid hormones exert their effects through alpha (TRα1) and beta (TRβ1 and TRβ2)
receptors. Here we describe a child with classic features of hypothyroidism (growth …

Predictive biomarkers: a paradigm shift towards personalized cancer medicine

NB La Thangue, DJ Kerr - Nature reviews Clinical oncology, 2011 - nature.com
Advances in our understanding of the intricate molecular mechanisms for transformation of a
normal cell to a cancer cell, and the aberrant control of complementary pathways, have …